# Ritodrine

## Anpo inj 50mg/5mL

| 藥物代碼 | IANP |
| :--- | :--- |
| 適應症 | Prevention of preterm labour, Acute fetal distress, Prevention of preterm labour after operation. |
| 副作用 | Pulmonary oedema \(several cases reported with fatal results\). Maternal & foetal heart rate can increase. Frequently: Tremor, nausea, vomiting, headache or erythema, nervousness, restlessness, jitteriness, emotional upset, anxiety or malaise. Infrequently cardiac symptoms, eg chest pain or tightness with or without ECG abnormalities & cardiac arrhythmias. Hepatic impairment. |
| 禁忌 | Antepartum haemorrhage due to any cause but particularly placenta previa & abruptio placentae. Eclampsia & severe pre-eclampsia. Intra-uterine foetal death. Chorioamnionitis. Maternal cardiac disorder. Hyperthyroidism. Uncontrolled hypertension. Any other condition which can endanger cardiac function. Parenteral: Asthmatics \(due to sulfite component\). |
| 藥物保存方式 | N/A |
| 用法用量 | Prevention of preterm labour IV infusion Initially 0.05 mg/min, to be gradually increased by 0.05 mg/min every 10-15 mins. IM inj 10 mg 4-6 hrly. Continue treatment for 12-48 hr after ceased contraction. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM, IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【L/R】 可選  【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 起始: 0.05 mg/min ，維持:0.15~0.35 mg/min，輸注液建議使用D5W，若使用N/S稀釋，將增加發生肺水腫之可能性。 |
| 注意事項 | 1. 輸注液建議使用D5W。若使用N/S稀釋，將增加發生肺水腫之可能性。\(衛生署公文：FDA藥字第1001409159號\) |

## Anpo 10mg

| 藥物代碼 | OANP |
| :--- | :--- |
| 適應症 | Prevention of preterm labour,  Acute fetal distress, Prevention of preterm labour after operation Follow treatment for preterm labour. |
| 副作用 | Pulmonary oedema \(several cases reported with fatal results\). Maternal & foetal heart rate can increase. Frequently: Tremor, nausea, vomiting, headache or erythema, nervousness, restlessness, jitteriness, emotional upset, anxiety or malaise. Infrequently cardiac symptoms, eg chest pain or tightness with or without ECG abnormalities & cardiac arrhythmias. Hepatic impairment. |
| 禁忌 | Antepartum haemorrhage due to any cause but particularly placenta previa & abruptio placentae. Eclampsia & severe pre-eclampsia. Intra-uterine foetal death. Chorioamnionitis. Maternal cardiac disorder. Hyperthyroidism. Uncontrolled hypertension. Any other condition which can endanger cardiac function. Parenteral: Asthmatics \(due to sulfite component\). |
| 藥物保存方式 | 室溫 |
| 用法用量 | Tab 1-2 tab 2-6 hrly. Max: 120 mg daily. Usually 80-120 mg equally divided over the day. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

